CONGENITAL DYSERYTHROPOIETIC ANEMIA (CDA)
Clinical trials for CONGENITAL DYSERYTHROPOIETIC ANEMIA (CDA) explained in plain language.
Never miss a new study
Get alerted when new CONGENITAL DYSERYTHROPOIETIC ANEMIA (CDA) trials appear
Sign up with your email to follow new studies for CONGENITAL DYSERYTHROPOIETIC ANEMIA (CDA), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could a bone drug fix a rare blood disorder?
Disease control Recruiting nowThis early study tests whether zoledronic acid, a drug usually used for bone health, can help people with a rare inherited anemia called congenital dyserythropoietic anemia (CDA). Only 2 adults with CDA who have low hemoglobin or need regular transfusions will receive 4 doses of …
Matched conditions: CONGENITAL DYSERYTHROPOIETIC ANEMIA (CDA)
Phase: PHASE1, PHASE2 • Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
Massive new registry aims to unlock secrets of rare blood disorder
Knowledge-focused Recruiting nowThis study is a registry for people with Congenital Dyserythropoietic Anemia (CDA), a rare blood disorder. Researchers will collect medical information and blood or bone marrow samples over many years to better understand how the disease progresses, its causes, and how it affects…
Matched conditions: CONGENITAL DYSERYTHROPOIETIC ANEMIA (CDA)
Sponsor: Children's Hospital Medical Center, Cincinnati • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
New study aims to personalize care for rare blood disorders
Knowledge-focused Recruiting nowThis study is for people with sickle cell disease or other rare anemias. Researchers want to use advanced genetic and blood tests to better understand each person's condition. The goal is to make diagnosis more precise so that treatments can be tailored to each patient. About 200…
Matched conditions: CONGENITAL DYSERYTHROPOIETIC ANEMIA (CDA)
Sponsor: Hospital Universitari Vall d'Hebron Research Institute • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:53 UTC